AtaGenix Laboratories Co., Ltd. is a contract research organization (CRO) specializing in custom antibody and recombinant protein solutions for research and drug development. Founded in 2011 within the Wuhan National Bio-Industry Base, AtaGenix operates as the designated Antibody Discovery and Screening Public Service Platform, serving global pharmaceutical, biotech, and academic partners with 15 years of project delivery experience.
The abinScience® brand was established in Strasbourg, France, drawing on AtaGenix’s 15 years of protein and antibody development expertise to deliver high-quality life science reagents. Since its founding in 2023, abinScience has been guided by its vision of “Empowering Bioscience Discovery,” committed to providing researchers worldwide with efficient and reliable experimental solutions to advance life science research.
Wuhan abinScience Biotechnology Co., Ltd., established in 2023, is the Asia-Pacific operations entity for the abinScience brand. It is responsible for reagent promotion, sales, and technical support across the Asia-Pacific market. The company leverages AtaGenix’s rigorous R&D framework and established international collaboration platform to deliver high-quality products and professional services to research institutions and pharmaceutical enterprises in the region.
View recombinant antibodies supplied by AtaGenix Laboratories on the database.
View AtaGenix Laboratories antibodies